Dr. Richardson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-2104Fax+1 617-632-6624- Is this information wrong?
Education & Training
- UMass ChanFellowship, Hematology and Medical Oncology, 1991 - 1994
- Charing Cross and Westminister Medical SchoolClass of 1986
Certifications & Licensure
- FL State Medical License 2022 - Present
- CT State Medical License 2022 - 2024
- MA State Medical License 1993 - 2024
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- Boston Magazine Castle Connolly, 2010-2013
- America's Top Doctors for Cancer Castle Connolly, 2010-2013
- Join now to see all
Clinical Trials
- High-dose ICE With Amifostine Start of enrollment: 1998 Jul 01
- Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation Start of enrollment: 2000 Apr 01
- Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma Start of enrollment: 2005 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethas...Rebecca Silbermann, Jacob Laubach, Jonathan L Kaufman, Douglas W Sborov, Brandi Reeves, Cesar Rodriguez, Ajai Chari, Luciano J Costa, Larry D Anderson Jr, Nitya Nathwa...> ;American Journal of Hematology. 2024 Apr 15
- Correction to: Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple m...Jooeun Bae, Teru Hideshima, Yu-Tzu Tai, Yan Song, Nikhil C Munshi, Paul Richardson, Noopur Raje, Kenneth C Anderson> ;Leukemia. 2024 Apr 15
- Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma.Annamaria Gulla, Eugenio Morelli, Megan Johnstone, Marcello Turi, Mehmet K Samur, Cirino Botta, Selma Cifric, Pietro Folino, Delaney Vinaixa, Francesca Barello, Cole C...> ;Blood. 2024 Mar 29
- Join now to see all
Journal Articles
- APRIL Signaling via TACI Mediates Immunosuppression by T Regulatory Cells in Multiple Myeloma: Therapeutic ImplicationsKenneth C Anderson, Nikhil Munshi, Paul Richardson, Chirag Acharya, Nature
- Twice‐Weekly Ixazomib in Combination with Lenalidomide‐Dexamethasone in Patients with Newly Diagnosed Multiple MyelomaMyo Htut, Michaela Liedtke, Stephen D Smith, Craig C Hofmeister, Rachid Baz, Paul G Richardson, Cara A Rosenbaum, David H Vesole, Ajai Chari, Jesus G Berdeja, Noopur Raje, British Journal of Haematology
- How I Treat the Young Patient with Multiple MyelomaPaul Richardson, MD, Blood
Abstracts/Posters
- Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) Patients Treated with Selinexor Plus Dexamethasone or Conventional Care: A Combined An...Paul G. Richardson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Influence of Cytogenetics in Patients with Relapsed Refractory Multiple Myeloma Treated with Oral Selinexor and Dexamethasone: A Post-Hoc Analysis of the STORM StudyPaul G. Richardson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Phase II Trial of the Combination of Ixazomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple MyelomaPaul G. Richardson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Dreamm-5: Platform Trial Evaluating Belantamab Mafodotin (a BCMA-directed Immuno-conjugate) in Combination with Novel Agents in Relapsed or Refractory Multiple Myeloma...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Current Obstacles in Myeloma Management: Debating the Evidence61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Results from Phase 1/2 Trial of Tagraxofusp in Combination with Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Press Mentions
- Study Shows That Immune System Holds Clues to Patients with High-Risk Smoldering Myeloma Likely to Benefit from TreatmentNovember 15th, 2022
- Why Breakthrough COVID Deaths Can Be MisunderstoodOctober 18th, 2021
- Analyzing Survival Outcomes with Ixazomib-Rd in Relapsed/Refractory Multiple MyelomaAugust 2nd, 2021
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
- Dana-Farber Cancer InstituteBoston, Massachusetts
- Brigham and Women's HospitalBoston, Massachusetts
- Salem HospitalSalem, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: